Study of Capmatinib in Indian Patients With MET Exon 14 Skipping Mutation Positive Advanced NSCLC.
Novartis
Novartis
Novartis
AstraZeneca
On Target Laboratories, LLC
Galvanize Therapeutics, Inc.
Bristol-Myers Squibb
Celgene
Beijing Zheng Ju Medical Technology Co., Ltd.
Novartis
CSA Medical, Inc.
CSA Medical, Inc.
Amgen
Janssen Korea, Ltd., Korea
Novartis